ZIEXTENZO

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 8c494249acbbca60
Drug Approval Canada Name: ZIEXTENZO
Product Name: ZIEXTENZO
Status: Marketed
Status Date: 2020-05-15
Original Market Date: 2020-05-15
Din: 02497395
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 20:16.00
Atc Original: L03AA13 PEGFILGRASTIM
Atc Name: l 03 aa 13
Aig Number: 0149962001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

PEGFILGRASTIM

6 MG / 0.6 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8c494249acbbca60

Type

Standard